Free Trial

WNS (WNS) Competitors

WNS logo
$75.43 -0.08 (-0.11%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$75.38 -0.05 (-0.06%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WNS vs. MEDP, RTO, STN, QXO, CART, BILI, FOUR, HQY, LIF, and ETSY

Should you be buying WNS stock or one of its competitors? The main competitors of WNS include Medpace (MEDP), Rentokil Initial (RTO), Stantec (STN), QXO (QXO), Maplebear (CART), Bilibili (BILI), Shift4 Payments (FOUR), HealthEquity (HQY), Life360 (LIF), and Etsy (ETSY). These companies are all part of the "business services" industry.

WNS vs. Its Competitors

WNS (NYSE:WNS) and Medpace (NASDAQ:MEDP) are both business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

97.4% of WNS shares are held by institutional investors. Comparatively, 78.0% of Medpace shares are held by institutional investors. 2.0% of WNS shares are held by insiders. Comparatively, 20.3% of Medpace shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Medpace has a net margin of 18.74% compared to WNS's net margin of 12.11%. Medpace's return on equity of 67.66% beat WNS's return on equity.

Company Net Margins Return on Equity Return on Assets
WNS12.11% 22.90% 12.02%
Medpace 18.74%67.66%21.86%

WNS presently has a consensus target price of $68.13, suggesting a potential downside of 9.68%. Medpace has a consensus target price of $406.60, suggesting a potential downside of 12.30%. Given WNS's stronger consensus rating and higher possible upside, equities analysts clearly believe WNS is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WNS
0 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Medpace
3 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.93

Medpace has higher revenue and earnings than WNS. WNS is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WNS$1.31B2.46$170.11M$3.5921.01
Medpace$2.11B6.18$404.39M$13.4534.47

WNS has a beta of 0.9, indicating that its stock price is 10% less volatile than the S&P 500. Comparatively, Medpace has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500.

In the previous week, Medpace had 8 more articles in the media than WNS. MarketBeat recorded 19 mentions for Medpace and 11 mentions for WNS. Medpace's average media sentiment score of 1.46 beat WNS's score of 0.73 indicating that Medpace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WNS
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Medpace
16 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Medpace beats WNS on 12 of the 15 factors compared between the two stocks.

Get WNS News Delivered to You Automatically

Sign up to receive the latest news and ratings for WNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WNS vs. The Competition

MetricWNSBUSINESS SVCS IndustryBusiness SectorNYSE Exchange
Market Cap$3.24B$5.75B$24.33B$20.92B
Dividend YieldN/A3.39%2.83%3.58%
P/E Ratio21.0129.5028.3829.13
Price / Sales2.461.8339.1252.98
Price / Cash14.6616.1625.7823.54
Price / Book4.064.866.025.45
Net Income$170.11M$155.37M$197.30M$992.10M
7 Day Performance0.59%-0.21%1.40%2.61%
1 Month Performance1.00%0.74%-2.53%1.46%
1 Year Performance23.43%56.07%32.76%10.72%

WNS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WNS
WNS
2.7794 of 5 stars
$75.43
-0.1%
$68.13
-9.7%
+26.4%$3.24B$1.31B21.0164,505
MEDP
Medpace
4.3543 of 5 stars
$462.91
+1.1%
$406.60
-12.2%
+20.0%$12.86B$2.11B34.425,900News Coverage
Positive News
Insider Trade
RTO
Rentokil Initial
2.3905 of 5 stars
$24.14
-1.6%
N/A-24.4%$12.39B$6.95B15.9968,485Positive News
STN
Stantec
3.2822 of 5 stars
$106.13
-0.1%
N/A+31.2%$12.12B$5.47B38.7332,000
QXO
QXO
3.7915 of 5 stars
$20.59
+0.4%
$32.25
+56.7%
+45.5%$11.95B$55.95M-2.26195News Coverage
Analyst Forecast
CART
Maplebear
4.7515 of 5 stars
$45.92
+4.6%
$55.46
+20.8%
+25.8%$11.57B$3.38B26.543,265Trending News
Analyst Forecast
Analyst Revision
BILI
Bilibili
2.7134 of 5 stars
$25.35
+2.0%
$23.81
-6.1%
+85.0%$10.39B$3.68B-126.748,088Trending News
Analyst Forecast
Options Volume
FOUR
Shift4 Payments
4.845 of 5 stars
$90.21
-0.7%
$114.40
+26.8%
+15.0%$8.03B$3.33B33.414,000
HQY
HealthEquity
4.21 of 5 stars
$89.53
-0.4%
$118.55
+32.4%
+19.5%$7.77B$1.20B65.353,120News Coverage
Positive News
LIF
Life360
1.1853 of 5 stars
$87.20
+2.1%
$86.43
-0.9%
+130.6%$6.62B$371.48M272.51600Insider Trade
ETSY
Etsy
3.912 of 5 stars
$64.96
-2.2%
$57.20
-11.9%
+16.5%$6.58B$2.81B52.392,400Analyst Forecast

Related Companies and Tools


This page (NYSE:WNS) was last updated on 8/23/2025 by MarketBeat.com Staff
From Our Partners